Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia (Q40722950)

23 September 2017

1 reference

title

Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia (English)

1 reference

23 September 2017

1 reference

Sawyers CL

1

1 reference

23 September 2017

1 January 1993

1 reference

23 September 2017

1 reference

23 September 2017

11 Suppl 2

1 reference

23 September 2017

101-103

1 reference

The molecular genetics of Philadelphia chromosome-positive leukemias

23 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Dominant negative MYC blocks transformation by ABL oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Bcr encodes a GTPase-activating protein for p21rac

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

Signal transduction through small GTPases—A tale of two GAPs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

High affinity DNA-binding Myc analogs: recognition by an alpha helix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064268

10.3109/10428199309064268

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8124222